Publishing research using ab72069? Please let us know so that we can cite the reference in this datasheet.

ab72069 has been referenced in 2 publications.

  • Dine JL  et al. The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and Axl. Breast Cancer Res Treat 155:235-51 (2016). IHC ; Human . PubMed: 26759246
  • Leconet W  et al. Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy. Oncogene N/A:N/A (2013). PubMed: 24240689

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"